Cite
HARVARD Citation
Fiore, S. et al. (2014). THU0275 IL-6 Receptor (IL-6R) Blockade with Sarilumab Reduced Circulating Markers Related to Synovial Inflammation and Structural Damage in Patients with Rheumatoid Arthritis (RA) in A Phase 2 Study. Annals of the rheumatic diseases. p. 278. [Online].